GALE - Galena Biopharma, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. Estimate-0.15-0.14-0.59-0.84
Low Estimate-0.15-0.14-0.59-0.84
High Estimate-0.15-0.14-0.59-0.84
Year Ago EPS-0.49-0.45-2.36-0.59
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.52-0.22-0.18-0.15
EPS Actual-0.49-0.45-0.22-0.02
Difference0.03-0.23-0.040.13
Surprise %5.80%-104.50%-22.20%86.70%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.15-0.14-0.59-0.84
7 Days Ago-0.15-0.14-0.59-0.84
30 Days Ago-0.15-0.14-0.59-0.84
60 Days Ago-0.15-0.14-0.59-0.84
90 Days Ago-0.19-0.38-0.71-1.39
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesGALEIndustrySectorS&P 500
Current Qtr.69.40%N/AN/A0.26
Next Qtr.68.90%N/AN/A0.27
Current Year75.00%N/AN/A0.08
Next Year-42.40%N/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A